Alexandru, N.; Andrei, E.; Safciuc, F.; Dragan, E.; Balahura, A.M.; Badila, E.; Georgescu, A.
Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defends Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells. Cells 2020, 9, 423.
https://doi.org/10.3390/cells9020423
AMA Style
Alexandru N, Andrei E, Safciuc F, Dragan E, Balahura AM, Badila E, Georgescu A.
Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defends Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells. Cells. 2020; 9(2):423.
https://doi.org/10.3390/cells9020423
Chicago/Turabian Style
Alexandru, Nicoleta, Eugen Andrei, Florentina Safciuc, Emanuel Dragan, Ana Maria Balahura, Elisabeta Badila, and Adriana Georgescu.
2020. "Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defends Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells" Cells 9, no. 2: 423.
https://doi.org/10.3390/cells9020423
APA Style
Alexandru, N., Andrei, E., Safciuc, F., Dragan, E., Balahura, A. M., Badila, E., & Georgescu, A.
(2020). Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defends Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells. Cells, 9(2), 423.
https://doi.org/10.3390/cells9020423